To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Atelocollagen vs. Prolotherapy in Partial-Thickness Supraspinatus Tears:

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2025

Atelocollagen vs. Prolotherapy in Partial-Thickness Supraspinatus Tears:

Vol: 307| Issue: 10| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Atelocollagen vs. Prolotherapy in Partial-Thickness Supraspinatus Tears: A Prospective Randomized Controlled Trial with MRI-Confirmed Outcomes.

Pain Physician . 2025 Jul;28(4):299-306.

Contributing Authors:
EJ Choi JH Lee D Lim M Chang PB Lee

Synopsis

Thirty-four patients with partial-thickness supraspinatus tears were randomized to ultrasound-guided prolotherapy with 20% dextrose (n=17) or atelocollagen injections (n=17), each delivered in three weekly sessions. The primary outcome was change in pain (VAS) to 3 months. Secondary outcomes were K-SPADI and SCSS at 1 and 3 months, and MRI-based changes in tear status from baseline to 3 months. Ov...

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue